Stay updated on Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, representing a minor backend/template update without changing the study content shown to users. No study data or functionality appears affected.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision metadata updated from v3.6.3 to v3.6.4 on the page, reflecting an updated documentation/versioning reference.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing v3.6.0, signaling a version update to the page's documentation rather than any change to the study details or results.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page now indicates that participant recruitment is closed, clarifying availability for the study. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates revision labeling, while a formatting change to the Intervention/Treatment header and the old revision note are removed.SummaryDifference0.4%

- Check78 days agoChange DetectedThe page now includes Revision: v3.5.5, replacing Revision: v3.5.4. This reflects a minor update to the page's revision metadata rather than substantive study information.SummaryDifference0.0%

- Check99 days agoChange DetectedAn addition of 'Revision: v3.5.4' and a deletion of 'Revision: v3.5.3' were made, reflecting a minor version update to the page.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.